Xencor, Inc.
Heterodimeric antibodies that bind CD3 and CD38
Last updated:
Abstract:
The present invention is directed to heterodimeric antibodies that bind CD3 and CD38.
Status:
Grant
Type:
Utility
Filling date:
25 Nov 2015
Issue date:
7 Jan 2020